Conciseness

The body is dense with genuinely non-obvious domain content (ToolUniverse tool parameters, gnomAD two-step workflow, fallback chains) that Claude cannot know, so it earns its tokens. But Phase 2.5's mechanism rationale paragraph ('annotation says an element is present, not whether this specific allele disrupts it...') and the discursive 'Handling Conflicting Evidence' narrative include explanation that could be tightened to direct tool-selection rules. This matches 'efficient; minor instances of over-explanation that could be trimmed', not the lean anchor at 5.

Actionability

Strong concrete guidance: copy-paste-ready `classify_acmg` and `ESM_explain_variant_mechanism` code, parameter tables for regulatory-prediction tools, and explicit fallback orderings. Falls short of fully executable because Phases 4 and 5 list bare tool names with the parameter details deferred to `TOOLS_REFERENCE.md`, which is not present in the bundle, and many tool invocations (e.g. `ClinVar_search_variants`) never show their calling signature.

Workflow Clarity

A clearly sequenced 6-phase pipeline (with 2.5/2.9/4.2/4.5 sub-phases), feedback loops via the 'Tool Failure Fallbacks' section, and checkpoints via 'Quantified Minimums' and a short-circuit ClinVar check. Minor validation gaps remain: the pre-delivery verification checklist is delegated to `CHECKLIST.md` which is absent, and per-phase 'capture/verify before proceeding' checkpoints are implicit. Anchor 4 ('clear sequence with most checkpoints present; minor validation gaps'), not 5, since the explicit validation checklist does not resolve.

Progressive Disclosure

The References section signals five one-level-deep files with one-line descriptions (good pattern), but no bundle files exist — `ACMG_CLASSIFICATION.md`, `CODE_PATTERNS.md`, `CHECKLIST.md`, `EXAMPLES.md`, and `TOOLS_REFERENCE.md` are all missing from the skill directory, so every reference is a dead end. Additionally, ~100 lines of Phase 6 (Bayesian point table, full `classify_acmg` implementation, gene-specific BS1 thresholds) inline the very content the body says lives in `ACMG_CLASSIFICATION.md` ('See ACMG_CLASSIFICATION.md for the complete algorithm'), which is the 'content that should be separate is inline' pattern of anchor 3.

Specificity

Lists multiple specific concrete actions covering the full pipeline: 'VUS classification, pathogenicity assessment with cited criteria, structure-based variant impact (AlphaFold/PDB), non-coding/regulatory variant effect prediction with sequence deep-learning models (AlphaGenome, Enformer, Borzoi, ChromBPNet, Evo 2), and producing clinical-grade variant reports'. Coverage spans raw calls to report output with no meaningful gaps, matching the comprehensive anchor rather than the 'minor gaps' anchor at 4.

Completeness

Explicitly answers both questions: what it does ('Clinical variant interpretation from raw variant calls to ACMG-classified recommendations with structural impact analysis') and when to use it ('Use this whenever a user asks about a variant's significance... or needs ACMG classification'). Voice is third person throughout, so no specificity penalty applies.

Trigger Term Quality

Natural user phrasing is comprehensively covered: "a variant's significance", "VUS classification", "pathogenicity", "intronic/promoter/enhancer/UTR non-coding variant's functional impact", "ACMG classification — even if they don't say 'ACMG'", plus named models and 'molecular tumor boards'. The explicit anticipation of users who omit the jargon ('even if they don't say ACMG') is exactly the synonym coverage the top anchor rewards.

Distinctiveness Conflict Risk

Clear clinical variant-interpretation niche (ACMG guidelines, ClinVar-style curation, return of results, molecular tumor boards) with triggers anchored to variant-significance questions; adjacent skills (e.g. general sequence analysis) are even routed via a separate cross-skill reference, keeping conflict risk minimal.